# Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy

> **NCT02352922** · PHASE4 · COMPLETED · sponsor: **AdventHealth** · enrollment: 64 (actual)

## Conditions studied

- Pain, Postoperative
- Surgical Procedure, Unspecified

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** Bupivacaine HCl

## Key facts

- **NCT ID:** NCT02352922
- **Lead sponsor:** AdventHealth
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02352922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02352922, "Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02352922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*